As part of our website, we use cookies to provide you with the highest level of service, including services tailored to your individual needs. By continuing to use the website without changing your cookie settings, you agree to the placement of cookies on your device as described in our Privacy Policy. You can change your cookie settings in your web browser at any time. Acceptance of essential cookies is required for the proper functioning of the website. For more detailed information, please refer to our PRIVACY POLICY.

Osocze

Support and optimization model of therapy with autologous platelet-rich plasma (PRP) – PLASMA

Key project elements:

  • Conducting comprehensive technological analyses aimed at optimizing the communication environment between medical facilities/doctors and PRP therapy patients, including defining the functional, visual, and technical characteristics of such solutions.
  • Development of algorithms for the pilot project of the PRP Therapy Hybrid System, optimizing PRP therapy processes, incorporating state-of-the-art solutions in machine learning and artificial intelligence.
  • Preparation of demonstration materials and a prototype of the PRP Therapy Hybrid System.

Project outcomes:

The project outcomes are focused on developing an innovative global information and communication solution:

  • A modern interactive tool for “patient-doctor-science” communication.
  • Distribution of knowledge about the effects of PRP therapy from real treatments among patients and doctors.
  • Support for doctors and patients in optimizing the outcomes of PRP therapy.
  • The world’s largest database on the effects of PRP therapy from real treatments.

Project participants:

  • Implementation: PRP Analytics Sp. z o.o. and the Łukasiewicz Research Network – EMAG Institute of Innovative Technologies.
  • Benefits for society and the economy: patients interested in PRP therapies, as well as medical facilities and doctors using PRP therapies.

Total project cost: 366,294 PLN, with 253,130 PLN contributed by European Funds.

This will close in 0 seconds